Skip to main content

Animations

Funded Studies

The Foundation supports research across basic, translational and clinical science to speed breakthroughs that can lead to the creation of new treatments and a better quality of life for people with Parkinson's disease.

Search or browse funded studies

Previously funded studies appear chronologically, with the most recent appearing first.

Filters
From
To
  • ${value}

Filter Results (2353${count})

  • Alpha-synuclein Seed Amplification Assay Program, 2022
    Development of a Reliable Diagnostic Test for Parkinson’s Disease Using Patient Blood Samples

    Study Rationale: Although diagnosis of Parkinson’s disease (PD) is crucial for the success of treatment, especially in the early stages, there are still no biomarkers available for use as a reliable...

  • Fall 2021 RFP: Accelerating Early Proof-of-Concept Testing of Promising PD Therapies, 2022
    Inhibiting Lrrk2 Specifically in the Brain

    Study Rationale: Neurodegenerative disorders such as Parkinson’s disease (PD) affect the brain. Some of the drugs designed to treat PD have unwanted side effects in the rest of the body. To minimize...

  • Fall 2021 RFP: Accelerating Early Proof-of-Concept Testing of Promising PD Therapies, 2022
    Phase 1b Trial to Assess the Safety and Efficacy of Dopamine Cell Transplants in Parkinson’s Disease Linked to Mutations in Parkin

    Study Rationale: We have shown that although cell transplants are able to produce dopamine and improve motor problems in some individuals with Parkinson’s disease (PD), differences in the quality of...

  • Diversity, Equity and Inclusivity in Parkinson's research, 2022
    Assessing the Awareness, Perception, Diagnosis, and Treatment of Parkinson’s Disease in Africa

    Study Rationale: Parkinson’s disease (PD) is little known in most parts of Africa and its symptoms are often ascribed to normal aging or to an unknown disorder. Most health care facilities lack the...

  • Fall 2021 RFP: Outcome Measures, 2022
    Use of Integrated, Multi-omic Data Analysis for Screening and Treatment of Parkinson’s Disease

    Study Rationale: Current diagnostic criteria and treatment options are designed for the “average” person with Parkinson’s disease (PD). This one-size-fits-all approach ignores the huge biological and...

  • Diversity, Equity and Inclusivity in Parkinson's research, 2022
    Engaging the LGBTQIA+ Community, Caregivers and Care Providers in Research on Living with Parkinson’s Disease

    Study Rationale: Four million LGBTQIA+ adults age 50 and above live in the United States. We know very little about the needs of those in the LGBTQIA+ community who are living with Parkinson’s disease...

Two female doctors talking in the lab.

Apply for a Grant

Our funding programs support basic, translational and clinical research from academia and industry.

See Funding Opportunities
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.